Asa's Regulatory Education Series
& Guest Appearances

The Organic & Natural Health Association
11th Annual Conference

This presentation will delve into the current marketing landscape surrounding GLP-1 in the U.S. supplement industry. Asa will look at biomarker enforcement, such as LDLs, to gain insights into marketing best practices, focusing on compliant strategies and pitfalls to avoid when promoting GLP-1-related products.

Unlock the secrets of dietary supplement regulations with Asa Waldstein, a seasoned regulatory consultant with a background in clinical herbalism. Discover the intricacies of FDA oversight in the supplement industry and learn why the notion that dietary supplements are unregulated is a myth. Asa’s journey from herbal studies in Boulder to advising companies on maintaining compliance provides unique perspectives and invaluable lessons for anyone navigating this complex field.

Noncompliant dietary supplement ingredient claims can be one of the reasons the Food and Drug Administration comes knocking. In this education session and interactive workshop, experts will dissect the U.S. regulations, laws and guidance that govern ingredient claims, as well as applicable court cases.

Navigating the complex landscape of dietary supplement regulations in the U.S. can be challenging. To help you stay ahead, Apex Compliance and FoodChain ID have teamed up to bring you an exclusive webinar.

Join industry experts Miguel Freitas, PhD, Vice President of Scientific Affairs for Danone North America; Kristina Campbell, Science and Medical writer; and Asa Waldstein, Principal of Supplement Advisory Group, for a look at ‘biotic supplement consumers.

Evaluate the Regulatory Landscape and Identify What You NEED to Know to Bring Your Functional Mushroom Product to Retail Shelves

Apex Compliance has been invited as a start up finalist. Asa Waldstein will be on stage as a "top 6" finalist in the most innovative digital solution for the nutraceutical industry.

10th Annual NoCo Hemp Expo

If you're curious about how new technology -- such as AI and blockchain -- can be applied to the dietary supplement industry, join us for the next AHPA webinar on April 9.

Asa reviews common pitfalls when marketing products that can lead to expensive litigation or agency action such as social media engagement, citing clinical studies, blogs, and influencer best practices.

Asa participates in "The Regulatory Universe & AI" discussion with Akash Shah.

Asa Waldstein speaks about Apex Compliance and accepts a NutraIngredients Start Up Stars Award. He also participates in Start Up Stars entrepreneur panel discussion.

Asa Waldstein participates in a panel discussion on AI and Amazon with David Trosin (NSF), Ryan Sensenbrenner (Enzymedica), and moderated by Quality of Life, Dan Lifton. This discussion takes place at the Organic and Natural Health Association's annual conference.

Reading the Tea Leaves (Part I): What 2024 Has In Store for Dietary Supplements Regulations and Compliance

Active Aging: Mastering the Market 2023

Bridging Compliance & Marketing with Asa Waldstein’s Unique Perspective

We will be reviewing top labeling mistakes that can result in lawsuits and costly re-prints.

Moderated by Asa Waldstein (Supplement Advisory Group), this session will feature discussion of the new FTC dietary supplement advertising guidance, the notices that followed, and the impact of both, as well as adequate claim substantiation.

Claims, regulatory compliance and messaging around microbiome ingredients

In this episode, Mason and Asa delve into all sorts of topics, and chat about substantiation dossiers, using puns as claims in marketing, general business advice, and more!

Join Radicle Perspectives with Asa Waldstein, Principal of Supplement Advisory Group, as we discuss how to mitigate label claim risk, the impact recent headlines have had on dietary supplement consumers, and what Asa sees is next when it comes to the FTC drama.

Asa teaches various GMP and marketing compliance classes at this three-day event.

This three-day intensive virtual conference will examine not only probiotics, prebiotics, synbiotics and postbiotics, but also numerous other microbiome- modulated interactions including the impact of stress and diet. Experts will examine leading-edge science, and deliver practical tools to leverage this science to competitive advantage and truly mastering the market.

Upcoming CEU Course
May 19th @ 12pm CST

In this session, Asa Waldstein (Supplement Advisory Group) will provide an overview of key considerations for label claims, with Amber Littlejohn (Ice Miller) and Jake Hebert (One Step Closer) expanding on health-related claims and environmental claims, respectively.

Regulatory and marketing panel

Asa Waldstein, Larisa Pavlick, Josh Long discuss dietary supplement GMPs and best practices.

Xavier interviews Asa Waldstein, founder of Apex Compliance and principal at Supplement Advisory Group.

Leaders in the natural products space share their experience on how to market claims and protect your brand.

Certifications, COA’s, Compliance & Claims

FDA Enforcement Trends + Social Media

Asa Waldstein presents a regulatory and enforcement update on notable action happening in emerging categories such as brain health; bone, muscle, and joint health; libido; immunity; heart health; eye health; and more!

​

Asa Waldstein reviews best practices, and common mistakes companies make when marketing and labeling hemp-CBD products.

The self-proclaimed 'warning letter geek' said lately the FDA is cracking down on mental health related-claims.

In this episode, Shayda Torabi welcomes Asa Waldstein. Asa  shares about his “Warning Letter Wednesday” emails, where he breaks down the FDA warning letters. He also talks about what an FDA warning letter might be and how it plays a major role in regulating CBD products right now as hemp is federally legal.

Asa Waldstein reviews common marketing pitfalls to avoid, such as social media engagement, hashtags, reposting, product reviews, citing studies, and blogs.

Asa discusses common marketing pitfalls in the open forum presentation. This involves lots of audience participation and questions.

If you've wanted to learn more about this continually emerging, high-growth industry, Naturally Boulder has assembled a panel of experts to discuss the state of the industry, what's hot and new, and how you can develop and build a powerhouse brand in the space. I showed up as an attendee, but due to a late panelist dropout, I was asked to speak, and it was fun!

Regulatory Snapshot: A review of enforcement trends, risks, and best practices for manufacturers and marketers in the stress and mental wellness space.

In this interactive discussion, Asa Waldstein reviews common and preventable mistakes companies make when selling supplements online.

This webinar is designed to help businesses in the dietary supplement industry understand the elements of current Good Manufacturing Practice (cGMP) regulations (21 CFR 111) that are the primary focus during U.S. Food and Drug Administration (FDA) facility inspections.

Asa Waldstein joins the Atlantia team to discuss how to use clinical data for marketing purposes to overcome regulatory hurdles that many CBD companies are encountering when commercializing their innovations.

There is much that can go wrong when entering the US cannabinoid or supplement marketplace. In this session we discuss how to avoid common labeling, product manufacturing, registration, and marketing errors that can delay launches, or worse, attract the attention of the FDA and class action attorneys.

Asa Waldstein presents a regulatory and enforcement update on notable action happening in the microbiome space.

Asa Waldstein trains future regulatory compliance professionals.

This course reviews common product online and social media marketing pitfalls to avoid.

Speakers: Josh Hendrix, Jonathan Miller, Asa Waldstein, Samantha Walsh, Marielle Weintraub

Today, there are a number of congressional bills and legislative and regulatory activity that can have an impact the hemp industry. Join this expert panel for an overview and analysis of key political, policy and regulatory activity that require the hemp industry’s attention, and how producers and marketers of CBD and other cannabinoids, in particular, can remain compliant in the face of USDA, FDA, EPA and other regulatory oversight.

A 3-Day Conference for Emerging Herbal Businesses